Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Mandala Biosciences (United States) | Researchclopedia

Back to institutions

Mandala Biosciences (United States)

La Jolla, Californiacompany

35

Works

1,305

Citations

14

h-index

Top Research Topics

Advanced biosensing and bioanalysis techniques Pluripotent Stem Cells Research LGBTQ Health, Identity, and Policy

Top Researchers

Antonio J. Ricco Ames Research Center

434 works12,851 citationsh-index: 53

Recent Research

84MO Phase I study of the tetravalent death receptor 5 (DR5) agonist ozekibart (INBRX-109) combined with irinotecan (I) and temozolomide (T) in adolescents and adults with Ewing sarcoma

Rashmi Chugh,Breelyn A. Wilky,et al.

20260 citations

Cancer Immunotherapy and Biomarkers

Mesenchymal stem cell research

Mental Health Treatment and Access

CRISPR and Genetic Engineering

Monoclonal and Polyclonal Antibodies Research

CAR-T cell therapy research

Employee Performance and Motivation

Financial Analysis and Corporate Governance

Amino Acid Enzymes and Metabolism

Tim Croudace University of Dundee

205 works12,090 citationsh-index: 59

Z. Hugh Fan Jiangsu University

218 works11,163 citationsh-index: 47

Arthur A. Levin Genomics Institute of the Novartis Research Foundation

197 works11,070 citationsh-index: 49

John W. Kozarich

192 works9,440 citationsh-index: 47

Walter Pierre Bouman

146 works9,282 citationsh-index: 42

EXTH-100. Tetravalent death receptor 5 (DR5) agonist ozekibart (INBRX-109) exhibits anti-tumor activity in GBM models as a monotherapy and in combination with TMZ

Katelyn M. Willis,William Crago,et al.

20250 citations

Marketing Strategy Analysis in an Efforts to Attrack Customers' Interest in Choosing Sajadah Savings at KSPPS BMT NU, East Java Branch, Tegalampel, Bondowoso

Dwi Ratnasari,Supranoto,et al.

20250 citations

INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering

Nisha Holay,Rashi Yadav,et al.

20259 citations

Determinan Penghindaran Pajak pada Perusahaan Sektor Industri Barang Konsumsi (Consumer Non-Cycical)

Mohammad Mustofa,Muhaimin Dimyati,et al.

20250 citations

Pendampingan UMKM Desa Tanggul Wetan dalam Memperoleh Nomor Induk Berusaha (NIB)

Hafiz Rafi Altair,Elsa Firlana Dewi,et al.

20240 citations